Background: Patients with chronic kidney disease (CKD) manifest an increased prevalence of cardiovascular morbidity and mortality compared with age-matched persons, and this relationship is directly proportional to the severity of CKD. After age, left ventricular hypertrophy (LVH) is considered to be the strongest independent predictor of cardiovascular disease and events, cardiovascular death and total mortality. In CKD patients, LVH contributes to diastolic dysfunction, congestive heart failure, arrhythmia and sudden death.
INTRODUCTION
n the haemodialysis (HD) population left ventricular dysfunction (LVDys) is common with a rate 10-30 times greater than that in the general population. The clinical diagnosis of congestive heart failure (CHF) in the HD population, which may be due to decreased left ventricular function, correlates strongly with mortality, having a reported 3-year survival of only 17% (1) The traditional risk factors for cardiovascular disease do not completely explain this high risk, which seems to be influenced by the so-called nontraditional risk factors associated with CKD. This set of factors accelerates the course of coronary artery disease and is associated with a higher prevalence of ventricular hypertrophy, myocardial fibrosis, valvulopathies, arrhythmias, and sudden death (2) PATIENTS AND METHODS This is a cross sectional study that included 90 patients who diagnosed as endstage renal failure on regular HD. They were recruited from the nephrology and dialysis unit of internal medicine Department and Cardiology Department, Zagazig University hospitals, from September 2017 to March 2018. Patients included in this study were on HD had been on regular 4 h HD sessions three times per week for at least 6 months. Patients were divided according to the history taking:
Group (1) 
The entire study population underwent echocardiography, including both conventional and tissue Doppler imaging of the LV and the. Echocardiography was performed within 1 h after the completion of HD while the patients were at optimal dry weight to avoid any overestimation of pulmonary pressure because of volume overload. Images were obtained using a Philips iE33 (Philips Healthcare, Massachusetts, USA) with 2 and 2.5MHz.
The study was carried out according to the criteria of the American Society of Echocardiography, 2017. LV volumes were estimated using the z-derived method. Ejection fraction (EF) of the LV was calculated using the Teicholz formula and further confirmed using Simpson's technique in the four-chamber view. The maximal tricuspid regurgitation velocity was measured by continuous wave Doppler echocardiography from the apical fourchamber view. The highest peak velocity was recorded and the average peak velocities from three beats were calculated. The table shows -That BMI, Serum Ca and HTN were found to be independent risk factor for LVDD in CKD on HD. DISCUSSION There was a significant difference between the group regarding sex and HD duration. Unlike our findings [5] reported no statistically significant differences were found among the groups in their age, sex, BMI and smoking, and systolic blood pressure; however, there was a significant increase in diastolic blood pressure and heart rate.
STATISTICAL ANALYSIS
We found that there was a significant difference between the two groups regarding echo changes and no significant regarding EF. Similarly to [6] and [5] who found that the EF was significantly lower in HDpatients. However , [7] found no difference in theleft ventricle ejection fraction (LVEF) between the HDgroup and the control group. The difference may be attributed to a relativelyshorter duration of dialysis in our study patients than thatin the study of [6] The prevalenceof LVH in the general population is 15-21%, but itaffects 50-70% of patients during intermediate stages of CKDand up to 90% of patients with end-stage kidney disease [8] In a cross-sectional study of 3487 participants of the ChronicRenal Insufficiency Cohort Study, the prevalence of LVH assessedby echocardiography was 32, 48, 57 and 75% for estimatedglomerular filtration rate (eGFR) categories ≥60, 45-59,30-44 and <30 mL/min per 1.73 m2, respectively. In fullyadjusted multivariable analyses, subjects with eGFR levels of <30mL/min per 1.73 m2 had 2-fold higher odds of LVH(OR=2.20,95% CI = 1.40-3.40; P < 0.001) relative to subjects with eGFRlevels of ≥60 mL/min per 1.73 m 2([9] .
In a Spanish generalpractice multicentre study of 13,687 hypertensive patients, the relationshipbetween electrocardiographic (EKG)-LVH and CKDstage was present in women but absent in men [10] . In our study we found that there a statistically significant decrease in hemoglobin in the patients with comorbidities compared to patients without comorbidities In agree with our results [5] found that in the HD group compared with the control group and astatistically significant decrease in blood hemoglobin. But they disagree with us that they found a significant increase inblood urea, serum creatinine, potassium, and phosphorsin the HD group compared with the control group and astatistically significant decrease in calcium. In our study, regarding the echo changes the most significant finding was grade 1 among the HD patients either in patients with comorbidities or without. However, there was a significant difference between the two studied group. We also found no significant difference between the two group.
[11] documented the same finding regarding Echo changes. Also others authors reported the same results We found a negative significant correlation between EF with HD duration, PTH, calcium, phosphorus and hemoglobin in the hemodialysis patients. We also documented the same relation in both group, this suggesting the prolonged HD duration is the main risk for comorbidities. Our finding agreed with finding of Ahmed et al. 2016 who reported a negative significant correlation between EF with calcium and HD duration, but they disagreed with us that they found a positive significant correlation between EF with hemoglobin, creatinine, uric acid and phosphorus. In our study we found that BMI, Serum Ca and HTN were found to be independent risk factor for LVDD in CKD patients on HD. suggest thateven with levels of eGFR above 60, there is a relationshipbetween kidney function and cardiac function. Diastolic dysfunction is closely associated withleft ventricular hypertrophy (LVH). LVH is knownto occur in > 70% of incident ESRD patients and increasesthe risk for cardiovascular event. LVH hasbeen shown to be an important independent predictorof cardiovascular outcome in ESRD patients diastolic dysfunction is a powerful predictor of all-causemortality in advanced CKD patient
In conclusion, LVDys is highly prevalent in HD patients and confers a worse prognosis in this already highly comorbid population. The most commonly used measurement technique, 2D echocardiography, can lead to underestimation of LV function rendering interpretation of the literature problematic. The routine use of modern measurement techniques will hopefully allow for more accurate estimates of prevalence.
